Skip to main content
editorial
. 2013 Dec;2(4):278–280. doi: 10.3978/j.issn.2223-4683.2013.09.13

Table 1. Castrate resistant prostate cancer treatment side effects.

Drug Median OS (months) S/E
Mitoxantrone No improvement, but improved symptom palliation Dyspnea, mucositis, cytopenias, cardiac dysfunction
Docetaxel 2.9 (mitoxantrone/prednisone) Neutropenia, neuropathy, fatigue, N/V, alopecia, diarrhea, dyspnea, tearing, peripheral edema, nose bleeds
Sipuleucel-T 4.1 (placebo/prednisone) Chills, HA, fever
Abiraterone 4.6 (post-docetaxel, placebo/prednisone) Fatigue, arthralgia, peripheral edema, anemia, back pain, bone pain, hypokalemia
Cabazitaxel 2.4 (post-docetaxel, mitoxantrone/prednisone) Neutropenia, diarrhea, N/V
Enzalutamide 4.8 (post-docetaxel, placebo/prednisone) Fatigue, diarrhea, hot flashes, seizures
Radium-223 dichloride 2.8 (placebo) Nausea, vomiting, peripheral edema

OS, overall survival; S/E, side effects; N/V, nausea, vomiting; HA, headache.